Clinical Trials in Leeds - 22 Recruiting Industry Studies

Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
Boehringer Ingelheim · started 2025-09-13

📍 Antrim · Bath · Birmingham · Leeds · London

NCT06806592 on ClinicalTrials.gov ↗

Active Phase 3

Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)

CLL
BeOne Medicines · started 2023-11-11

📍 Bournemouth · Canterbury · Headington · Leeds · Liverpool

NCT06073821 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

Type 1 Diabetes Mellitus
Sanofi · started 2025-08-06

📍 Cambridge · Dundee · London · Glasgow · Bath

NCT07088068 on ClinicalTrials.gov ↗

Recruiting Phase 2/Phase 3

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Bicara Therapeutics · started 2025-01-28

📍 Aberdeen · Birmingham · Cambridge · Glasgow · Leeds

NCT06788990 on ClinicalTrials.gov ↗

Recruiting Phase 3

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV
AstraZeneca · started 2026-05-05

📍 Edinburgh · Hampshire · Leeds · London · Manchester

NCT07509151 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor

Paroxysmal Nocturnal Hemoglobinuria (PNH), Persistent Anemia
Regeneron Pharmaceuticals · started 2026-02-11

📍 Leeds · London

NCT07187401 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
Boehringer Ingelheim · started 2024-05-06

📍 Aberdeen · Birmingham · Bristol · Edinburgh · Exeter

NCT06238622 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma
Boehringer Ingelheim · started 2024-06-03

📍 Cardiff · Leeds · London · Manchester · Newcastle upon Tyne

NCT06324357 on ClinicalTrials.gov ↗

Recruiting Phase 3

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

Healthy
Pfizer · started 2025-08-25

📍 Bristol · London · Manchester · Truro · Southampton

NCT07160244 on ClinicalTrials.gov ↗

Active Phase 3

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

Follicular Lymphoma (FL)
Genmab · started 2022-09-20

📍 Plymouth · Glasgow · London · Oxford · Leeds

NCT05409066 on ClinicalTrials.gov ↗

By invitation Phase 3

An Open-label Study of XEN1101 in Epilepsy

Focal Epilepsy, Tonic-Clonic Seizures
Xenon Pharmaceuticals Inc. · started 2023-04-25

📍 Leeds · Cardiff · Birmingham · London · Oxford

NCT05718817 on ClinicalTrials.gov ↗

Recruiting Phase 1

Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Cancer, HGSOC, HGS Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Epitopea Ltd · started 2026-07

📍 Cambridge · Edinburgh · Glasgow · Leeds · Leicester

NCT07665515 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
BeOne Medicines · started 2025-06-11

📍 Bournemouth · Leeds · London · Metropolitan Borough of Wirral · Newcastle upon Tyne

NCT06943872 on ClinicalTrials.gov ↗

No trials match your search.

Browse by city

London · 118 Manchester · 30 Glasgow · 27 Cambridge · 27 Birmingham · 24 Leicester · 23 Bristol · 23 Leeds · 22 Sutton · 19 Oxford · 19 Liverpool · 18 Edinburgh · 15 Nottingham · 14 Cardiff · 14 Newcastle upon Tyne · 13 Sheffield · 12

Browse by condition

Obesity · 5 Chronic Lymphocytic Leukemia · 5 Cancer · 4 Breast Neoplasms · 3 Non-small Cell Lung Cancer · 3 Small Lymphocytic Lymphoma · 3 Multiple Myeloma · 3 Hypertension · 3 Heart Failure · 3 Triple Negative Breast Neoplasms · 2 Lymphoma, Non-Hodgkin · 2 Lymphoma, Follicular · 2 Lymphoma, Large B-Cell, Diffuse · 2 Gastric Cancer · 2 Metastatic Prostate Cancer · 2 Overweight · 2

Cite this page

Priya Life Science (2026). Clinical Trials in the UK Tracker. Available at: https://priyalifescience.com/clinical-trials-uk/city/leeds (Accessed: 11 July 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one UK site, most recently updated first, refreshed daily. This is a curated slice of the registry, not every UK trial; UK studies may also be registered on ISRCTN. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our UK Pharma Salary Guide, or see our Ireland, EU and USA trackers.